Indian pharma set to boost generic strength as patent for Ozempic, Vegovy expires today business News & more related News Here
India’s pharma industry is set to boost its generic power as the patent on a key ingredient of blockbuster weight loss drugs expires today. Pharmarack estimates India’s weight loss drug market to grow from about ₹1,500 crore today to ₹8,000 crore by 2030. (Reuters) More than 40 Indian drugmakers are preparing to launch more than…
